What’s New
We share news about new product features, our thoughts on recent developments at MedaSystems or in the industry at large. Scroll down for a chronological view, or jump to posts using the categories to the left.
Expanding Access Worldwide: How MedaSystems Helps Bring Therapies to Patients Across the Globe
Expanded Access Programs help patients with serious or life-threatening conditions access investigational therapies when other treatment options are limited. Discover how MedaSystems helps pharmaceutical and biotechnology organizations centralize, automate and scale Expanded Access programs across patients, therapies and markets worldwide.
The Biggest Challenges Facing Expanded Access Programs—and How Leading Pharmaceutical Companies Are Responding
As Expanded Access programs become more global and complex, pharmaceutical companies need scalable ways to manage requests, maintain compliance, and support patients faster.
Saving Lives Beyond Clinical Trials: How Expanded Access Programs Are Transforming Global Patient Care
For thousands of patients around the world, the difference between hope and heartbreak often comes down to time.
Build vs. Buy in Expanded Access Programs: Finding the Right Balance for Patient Access
As expanded access and managed access programs become increasingly important components of patient access strategy, biopharmaceutical companies face a critical question: which capabilities should be developed internally, and which are best supported through external expertise and technology partners?